BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 18821488)

  • 1. Toxicity in rhesus monkeys following administration of the 8-aminoquinoline 8-[(4-amino-l-methylbutyl)amino]- 5-(l-hexyloxy)-6-methoxy-4-methylquinoline (WR242511).
    Rockwood G; Duniho S; Briscoe C; Gold M; Armstrong K; Kahler D; Moran A; Baskin S
    J Med Toxicol; 2008 Sep; 4(3):157-66. PubMed ID: 18821488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and kinetic-dynamic modeling of an 8-aminoquinoline candidate anticyanide and antimalarial drug (WR242511).
    Marino MT; Peggins JO; Brown LD; Urquhart MR; Brewer TG
    Drug Metab Dispos; 1994; 22(3):358-66. PubMed ID: 8070311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methemoglobin formation resulting from administration of candidate 8-aminoquinoline antiparasitic drugs in the dog.
    Anders JC; Chung H; Theoharides AD
    Fundam Appl Toxicol; 1988 Feb; 10(2):270-5. PubMed ID: 3356313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An improved pharmacodynamic model for formation of methemoglobin by antimalarial drugs.
    Fasanmade AA; Jusko WJ
    Drug Metab Dispos; 1995 May; 23(5):573-6. PubMed ID: 7587933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous modeling of the pharmacokinetics and methemoglobin pharmacodynamics of an 8-aminoquinoline candidate antimalarial (WR 238605).
    Brueckner RP; Fleckenstein L
    Pharm Res; 1991 Dec; 8(12):1505-10. PubMed ID: 1808614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A simple and rapid evaluation of methemoglobin toxicity of 8-aminoquinolines and related compounds.
    Srivastava P; Singh S; Jain GK; Puri SK; Pandey VC
    Ecotoxicol Environ Saf; 2000 Mar; 45(3):236-9. PubMed ID: 10702341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical anesthetic-induced methemoglobinemia and sulfhemoglobinemia in macaques: a comparison of benzocaine and lidocaine.
    Martin DG; Watson CE; Gold MB; Woodard CL; Baskin SI
    J Appl Toxicol; 1995; 15(3):153-8. PubMed ID: 7560734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Studies on the tissue schizonticide of malaria parasite: synthesis of 5-trieluoroacetyl-primaquine and its derivatives].
    Zheng XY; Chen C; Fang W
    Yao Xue Xue Bao; 1992; 27(6):423-7. PubMed ID: 1442069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyanide toxicity in mice pretreated with diethylamine nitric oxide complex.
    Baskin SI; Nealley EW; Lempka JC
    Hum Exp Toxicol; 1996 Jan; 15(1):13-18. PubMed ID: 8845203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methemoglobin toxicity and hematological studies on malaria anti-relapse compound CDRI 80/53 in dogs.
    Puri SK; Srivastava R; Pandey VC; Sethi N; Dutta GP
    Am J Trop Med Hyg; 1989 Dec; 41(6):638-42. PubMed ID: 2641641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-activity relationships of putative primaquine metabolites causing methemoglobin formation in canine hemolysates.
    Link CM; Theoharides AD; Anders JC; Chung H; Canfield CJ
    Toxicol Appl Pharmacol; 1985 Nov; 81(2):192-202. PubMed ID: 4060148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Causal prophylactic activity of a new 8-aminoquinoline derivative against Plasmodium cynomolgi B in rhesus monkeys.
    Puri SK; Dutta GP
    Indian J Med Res; 1990 May; 91():197-9. PubMed ID: 2397941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Species comparison of methemoglobin reductase.
    Rockwood GA; Armstrong KR; Baskin SI
    Exp Biol Med (Maywood); 2003 Jan; 228(1):79-83. PubMed ID: 12524477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of methemoglobin formers in protection against the toxic effects of cyanide.
    Scharf BA; Fricke RF; Baskin SI
    Gen Pharmacol; 1992 Jan; 23(1):19-25. PubMed ID: 1592224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Toxicity and repository antimalarial activity of octanoyl primaquine].
    Zhang S; Yao WZ; Su L; Zhang J
    Zhongguo Yao Li Xue Bao; 1982 Dec; 3(4):270-3. PubMed ID: 6219545
    [No Abstract]   [Full Text] [Related]  

  • 16. Primaquine analogues: derivatives of 4-amino-2-methoxyacridine.
    Scovill JP; Klayman DL; Woods TS; Sweeney TR
    J Med Chem; 1979 Oct; 22(10):1164-7. PubMed ID: 117105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subacute toxicity of primaquine in dogs, monkeys, and rats.
    Lee CC; Kinter LD; Heiffer MH
    Bull World Health Organ; 1981; 59(3):439-48. PubMed ID: 6976851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primaquine-induced hemolytic anemia: formation and hemotoxicity of the arylhydroxylamine metabolite 6-methoxy-8-hydroxylaminoquinoline.
    Bolchoz LJ; Budinsky RA; McMillan DC; Jollow DJ
    J Pharmacol Exp Ther; 2001 May; 297(2):509-15. PubMed ID: 11303037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of hematologic consequences and efficacy of p-aminophenones in mice.
    Rockwood GA; Baskin SI; Romano JA; Murrow ML; Preville JA; Lee RB; Sweeney RE
    Environ Toxicol Pharmacol; 1999 Oct; 7(4):237-52. PubMed ID: 21781932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of a bulky 2-tert-butyl group containing primaquine analogue that exhibits potent blood-schizontocidal antimalarial activities and complete elimination of methemoglobin toxicity.
    Jain M; Vangapandu S; Sachdeva S; Singh S; Singh PP; Jena GB; Tikoo K; Ramarao P; Kaul CL; Jain R
    J Med Chem; 2004 Jan; 47(2):285-7. PubMed ID: 14711300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.